| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/1381612822666151221150733 |
| P8608 | Fatcat ID | release_3v33cqwz25dopkytscywwzrilq |
| P932 | PMC publication ID | 4900538 |
| P698 | PubMed publication ID | 26685681 |
| P50 | author | David S Hersh | Q56281826 |
| Graeme F Woodworth | Q87718669 | ||
| P2093 | author name string | Jeffrey A Winkles | |
| Anthony J Kim | |||
| Victor Frenkel | |||
| Nathan Roberts | |||
| Aniket S Wadajkar | |||
| Jimena G Perez | |||
| Nina P Connolly | |||
| P2860 | cites work | The blood-brain barrier: bottleneck in brain drug development | Q22336985 |
| Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index | Q24648329 | ||
| Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion | Q48438732 | ||
| Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas | Q48443469 | ||
| Demonstration of potential noninvasive ultrasound brain therapy through an intact skull | Q48486462 | ||
| Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study | Q48508934 | ||
| Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion | Q48509398 | ||
| Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo | Q48548605 | ||
| Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound | Q48558167 | ||
| Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors | Q48587395 | ||
| Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo | Q48643049 | ||
| Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin | Q48732717 | ||
| Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies | Q48753747 | ||
| The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence | Q48797548 | ||
| Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment | Q48825956 | ||
| Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients | Q48883553 | ||
| The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles | Q48938424 | ||
| Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. | Q48938600 | ||
| Intracerebral chemotherapy: chronic microinfusion of cisplatin | Q48968255 | ||
| Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption | Q50245668 | ||
| Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles | Q50250294 | ||
| Perspectives in clinical uses of high-intensity focused ultrasound | Q50250329 | ||
| Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo | Q50253319 | ||
| MR temperature mapping of focused ultrasound surgery | Q50253383 | ||
| Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. | Q50769501 | ||
| Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. | Q51421065 | ||
| Multi-pulse drug delivery from a resorbable polymeric microchip device. | Q51797551 | ||
| Functionalized carbon nanotubes: revolution in brain delivery. | Q52150149 | ||
| Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. | Q52305456 | ||
| Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. | Q52503107 | ||
| Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. | Q52503294 | ||
| Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. | Q52525691 | ||
| Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. | Q52537604 | ||
| A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier | Q36267668 | ||
| Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. | Q36273509 | ||
| Erosion of a new family of biodegradable polyanhydrides | Q36718117 | ||
| Intranasal delivery: physicochemical and therapeutic aspects | Q36809401 | ||
| Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers | Q36838213 | ||
| Blood-brain barrier transport of therapeutics via receptor-mediation | Q36874295 | ||
| Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors | Q36926763 | ||
| Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter. | Q37041266 | ||
| Convection-enhanced delivery of M13 bacteriophage to the brain | Q37205691 | ||
| Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents | Q37275419 | ||
| Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience | Q37280734 | ||
| Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier | Q37312010 | ||
| Nanoparticles for direct nose-to-brain delivery of drugs. | Q37531152 | ||
| Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model | Q37566698 | ||
| Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound | Q37725032 | ||
| Strategy for effective brain drug delivery. | Q37760347 | ||
| Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours | Q37769645 | ||
| Intranasal delivery of biologics to the central nervous system | Q37961386 | ||
| Lipid-based nanocarriers for CNS-targeted drug delivery | Q37979219 | ||
| Going against the tide--how encephalitogenic T cells breach the blood-brain barrier | Q38040667 | ||
| Liposomes for brain delivery | Q38078421 | ||
| Advances in stem cell therapy against gliomas | Q38093919 | ||
| From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? | Q38133556 | ||
| The role of Gliadel wafers in the treatment of high-grade gliomas | Q38162925 | ||
| Chemokines and chemokine receptors: positioning cells for host defense and immunity | Q38198156 | ||
| Convection-enhanced delivery to the central nervous system | Q38268184 | ||
| Overcoming the blood-brain tumor barrier for effective glioblastoma treatment | Q38384505 | ||
| Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind Study | Q38557135 | ||
| Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. | Q38559786 | ||
| The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial | Q38562276 | ||
| Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants. | Q38564845 | ||
| Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group | Q38573324 | ||
| Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat model | Q38898293 | ||
| In vivo delivery of siRNA to the brain by carbosilane dendrimer. | Q38923228 | ||
| Convection-enhanced delivery of MANF--volume of distribution analysis in porcine putamen and substantia nigra. | Q38974007 | ||
| Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models | Q38990060 | ||
| In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans. | Q52538757 | ||
| An evaluation of the relationships between catheter design and tissue mechanics in achieving high-flow convection-enhanced delivery. | Q52610765 | ||
| Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. | Q55472266 | ||
| Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival. | Q55475500 | ||
| Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group. | Q55476295 | ||
| Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. | Q55479444 | ||
| Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. | Q55481682 | ||
| Macrophage Infiltration Into Experimental Brain Metastases: Occurrence Through an Intact Blood-Brain Barrier | Q56879978 | ||
| From nose to brain: understanding transport capacity and transport rate of drugs | Q56893840 | ||
| Drug transport across the blood-brain barrier | Q57677287 | ||
| A controlled-release microchip | Q59058736 | ||
| Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion | Q71694555 | ||
| Localization of exogenous silver in brain and spinal cord of silver exposed rats | Q71814806 | ||
| Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthiourea | Q72997694 | ||
| Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. I. In vitro degradation | Q77718593 | ||
| Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells | Q78791582 | ||
| Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting | Q79800961 | ||
| Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells | Q80077858 | ||
| T lymphocytes as potential therapeutic drug carrier for cancer treatment | Q82479970 | ||
| The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier | Q83814322 | ||
| Drug delivery and nanoparticles:applications and hazards | Q24655744 | ||
| Development, maintenance and disruption of the blood-brain barrier | Q26829668 | ||
| Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines | Q27002209 | ||
| Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models | Q27301343 | ||
| Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model | Q27302402 | ||
| Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound | Q27312535 | ||
| Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment | Q27322329 | ||
| Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 | ||
| Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target | Q28238573 | ||
| The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound | Q28269056 | ||
| Blood-brain barrier transcytosis of insulin in developing rabbits | Q28295704 | ||
| Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications | Q28297458 | ||
| Receptor-mediated transcytosis of transferrin across the blood-brain barrier | Q28303216 | ||
| A review of nanoparticle functionality and toxicity on the central nervous system | Q28383491 | ||
| The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo | Q28392435 | ||
| Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain | Q28394137 | ||
| Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma | Q28546653 | ||
| Structure and function of the blood-brain barrier | Q29615699 | ||
| Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus | Q30394725 | ||
| Long-Term Safety of Repeated Blood-Brain Barrier Opening via Focused Ultrasound with Microbubbles in Non-Human Primates Performing a Cognitive Task | Q30412260 | ||
| Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma | Q30413487 | ||
| Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study | Q30416228 | ||
| Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy | Q30424484 | ||
| Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma | Q30431291 | ||
| Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model | Q30435074 | ||
| Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging | Q30435320 | ||
| Focused ultrasound delivers targeted immune cells to metastatic brain tumors | Q30441716 | ||
| Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model | Q30447321 | ||
| Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound | Q30447740 | ||
| Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma | Q30448863 | ||
| Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques | Q30452238 | ||
| Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier | Q30472787 | ||
| Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects | Q30474477 | ||
| Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain | Q30479578 | ||
| In vivo delivery of BCNU from a MEMS device to a tumor model | Q46707017 | ||
| Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results | Q46842679 | ||
| Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time | Q47271745 | ||
| Increased opening of blood-tumour barrier by leukotriene C4 is dependent on size of molecules | Q47403769 | ||
| Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics | Q48094101 | ||
| Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis | Q48100726 | ||
| Phase I study of GRN1005 in recurrent malignant glioma | Q48194717 | ||
| Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma | Q48209763 | ||
| Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption | Q48221757 | ||
| Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma | Q48295283 | ||
| Entry of neutralizing antibody to measles into brain and cerebrospinal fluid of immunized monkeys after osmotic opening of the blood-brain barrier | Q48348009 | ||
| Nanoparticle technology for delivery of drugs across the blood-brain barrier | Q48352217 | ||
| Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia | Q48357688 | ||
| Poor drug distribution as a possible explanation for the results of the PRECISE trial | Q48374857 | ||
| Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier | Q48408807 | ||
| Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab | Q48431844 | ||
| PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier | Q38997634 | ||
| cRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats | Q39007579 | ||
| Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression | Q39049644 | ||
| Multifunctional receptor-targeted nanocomplexes for the delivery of therapeutic nucleic acids to the brain | Q39110042 | ||
| Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. | Q39176028 | ||
| Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment | Q39225089 | ||
| Convection enhanced delivery of different molecular weight tracers of gadolinium-tagged polylysine | Q39373142 | ||
| Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity | Q39435865 | ||
| Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery | Q39722582 | ||
| The application of poly (glycerol-sebacate) as biodegradable drug carrier | Q39832146 | ||
| Transport across the blood-brain barrier using albumin nanoparticles | Q39854395 | ||
| Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation | Q40097009 | ||
| Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus | Q40314091 | ||
| Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). | Q40343421 | ||
| Implanted system for intraventricular drug infusion in central nervous system tumors | Q40853760 | ||
| Magnetic targeting of nanoparticles across the intact blood-brain barrier | Q40954233 | ||
| Enhanced delivery of [125I]glial cell line-derived neurotrophic factor to the rat CNS following osmotic blood-brain barrier modification | Q41144461 | ||
| Polymers for the sustained release of proteins and other macromolecules | Q42102243 | ||
| The selective binding and transmigration of monocytes through the junctional complexes of human endothelium | Q42204858 | ||
| Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system | Q43476719 | ||
| A simple synthetic route to the formation of a block copolymer of poly(lactic-co-glycolic acid) and polylysine for the fabrication of functionalized, degradable structures for biomedical applications | Q43586658 | ||
| Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury | Q43634635 | ||
| Hydrogels for combination delivery of antineoplastic agents | Q43717737 | ||
| Reversible osmotic opening of the blood-brain barrier in mice | Q43936306 | ||
| Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children | Q44156403 | ||
| Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications | Q44243665 | ||
| Osmotic opening of the blood-brain barrier in the monkey without associated neurological deficits | Q44245793 | ||
| Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells | Q44361209 | ||
| RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting | Q44523982 | ||
| Quantitative analysis of hyperosmotic and hypothermic blood-brain barrier opening | Q44749659 | ||
| Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter | Q44821882 | ||
| Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients | Q44918010 | ||
| Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption | Q44991153 | ||
| Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas | Q45325311 | ||
| Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles | Q45399982 | ||
| Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells | Q45866586 | ||
| Effective gene transfer into central nervous system following ultrasound-microbubbles-induced opening of the blood-brain barrier | Q45879620 | ||
| Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles. | Q45923880 | ||
| Design of an in-dwelling cannula for convection-enhanced delivery. | Q45989767 | ||
| Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. | Q45991678 | ||
| Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey. | Q46039689 | ||
| Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution | Q46063843 | ||
| Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation | Q46147948 | ||
| Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group | Q46232239 | ||
| Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system | Q46312640 | ||
| Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting | Q46442643 | ||
| Intranasal nanoemulsion based brain targeting drug delivery system of risperidone | Q46612913 | ||
| Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors | Q46641688 | ||
| Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium | Q30488665 | ||
| Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption | Q30489416 | ||
| NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery | Q30493643 | ||
| Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption | Q30500905 | ||
| A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue | Q30541682 | ||
| Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas | Q30885145 | ||
| A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease | Q33292093 | ||
| Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors. | Q33339811 | ||
| A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma | Q33504982 | ||
| Drug transport to brain with targeted liposomes | Q33569479 | ||
| Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease | Q33582089 | ||
| Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice | Q33697504 | ||
| Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival | Q33728678 | ||
| Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications | Q33851310 | ||
| Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier | Q33852356 | ||
| Cellular uptake mechanisms of functionalised multi-walled carbon nanotubes by 3D electron tomography imaging | Q33908641 | ||
| Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits | Q33954300 | ||
| Blood-brain barrier disruption following the internal carotid arterial perfusion of alkyl glycerols | Q33964235 | ||
| Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain | Q33966638 | ||
| Progress and problems in the neurological applications of focused ultrasound | Q33970135 | ||
| Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis | Q33984222 | ||
| Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound | Q33992793 | ||
| Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier | Q33999429 | ||
| Blood-brain barrier delivery | Q34001715 | ||
| Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound | Q34003611 | ||
| Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000. | Q34034080 | ||
| Size selectivity of blood-brain barrier permeability at various times after osmotic opening | Q34039576 | ||
| Testing of a hypothesis for osmotic opening of the blood-brain barrier | Q34053324 | ||
| Quantitative aspects of reversible osmotic opening of the blood-brain barrier | Q34057426 | ||
| Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery | Q34117089 | ||
| Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study | Q34132839 | ||
| The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation | Q34207241 | ||
| Drug delivery strategies for the treatment of malignant gliomas | Q34313142 | ||
| Transferrin-antibody fusion proteins are effective in brain targeting | Q34506062 | ||
| Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery | Q34564681 | ||
| Drug delivery to tumors of the central nervous system | Q34566426 | ||
| In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space | Q34600402 | ||
| Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes | Q34618201 | ||
| Liposomal drug delivery systems: an update review. | Q34708849 | ||
| Cell-mediated drug delivery. | Q34709440 | ||
| Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging | Q34714550 | ||
| Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption | Q34714906 | ||
| Drug and gene targeting to the brain with molecular Trojan horses | Q34742814 | ||
| Effect of concentration on the accuracy of convective imaging distribution of a gadolinium-based surrogate tracer | Q34954951 | ||
| Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier | Q35046193 | ||
| Convection-enhanced delivery of macromolecules in the brain | Q35091232 | ||
| The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain | Q35121360 | ||
| EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma | Q35145144 | ||
| Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans | Q35159477 | ||
| Real-time imaging of perivascular transport of nanoparticles during convection-enhanced delivery in the rat cortex. | Q35785766 | ||
| Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. | Q35796504 | ||
| Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma | Q35800532 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma | Q35894943 | ||
| A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma | Q35894958 | ||
| Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review | Q35899377 | ||
| Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells | Q35974503 | ||
| Nasal drug administration: potential for targeted central nervous system delivery | Q36109713 | ||
| Extended-duration analgesia: update on microspheres and liposomes | Q36129767 | ||
| Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core | Q36155333 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| blood–brain barrier | Q221694 | ||
| drug delivery | Q1392806 | ||
| P304 | page(s) | 1177-1193 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Current Pharmaceutical Design | Q5195068 |
| P1476 | title | Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier | |
| P478 | volume | 22 |
| Q38556802 | A bacteriophages journey through the human body. |
| Q38557213 | An overview of nanosomes delivery mechanisms: trafficking, orders, barriers and cellular effects |
| Q57152800 | Antibody-based tracers for PET/SPECT imaging of chronic inflammatory diseases |
| Q93049131 | Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis |
| Q60960607 | Blood-Brain Delivery Methods Using Nanotechnology |
| Q58550030 | Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis |
| Q38683003 | Calixarene-mediated liquid membrane transport of choline conjugates 3: The effect of handle variation on neurotransmitter transport |
| Q100464455 | Consistent opening of the blood brain barrier using focused ultrasound with constant intravenous infusion of microbubble agent |
| Q64105914 | Design, characterization and evaluation of a laser-guided focused ultrasound system for preclinical investigations |
| Q90731539 | Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties |
| Q58573420 | Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma |
| Q54970083 | Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme. |
| Q39128950 | Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting |
| Q92187504 | Empirical and Theoretical Characterization of the Diffusion Process of Different Gadolinium-Based Nanoparticles within the Brain Tissue after Ultrasound-Induced Permeabilization of the Blood-Brain Barrier |
| Q92349932 | Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer |
| Q60302950 | Liposome delivery systems for the treatment of Alzheimer's disease |
| Q92463724 | Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities |
| Q44516296 | Magnetic Enhancement of Stem Cell-Targeted Delivery into the Brain Following MR-Guided Focused Ultrasound for Opening the Blood-Brain Barrier |
| Q99408553 | Microglia-targeting nanotherapeutics for neurodegenerative diseases |
| Q64956054 | Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy. |
| Q64819927 | Neurotheranostics as personalized medicines |
| Q88630377 | Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from Pseudomonas fluorescens and In Silico Molecular Modeling |
| Q65556502 | Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles |
| Q57493450 | Photodynamic opening of the blood-brain barrier to high weight molecules and liposomes through an optical clearing skull window |
| Q59340082 | Possible strategies to cross the blood-brain barrier |
| Q33646512 | Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier |
| Q59803333 | QSAR and Molecular Docking Studies of the Inhibitory Activity of Novel Heterocyclic GABA Analogues over GABA-AT |
| Q61865897 | Scalable synthesis and validation of PAMAM dendrimer--acetyl cysteine conjugate for potential translation |
| Q89800666 | Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors |
| Q90381097 | Targeting with nanoparticles for the therapeutic treatment of brain diseases |
| Q47827576 | Therapeutic Potential of Novel Twin Compounds Containing Tetramethylpyrazine and Carnitine Substructures in Experimental Ischemic Stroke. |
| Q55417928 | Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives. |
| Q91131848 | Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain Barrier |
| Q33773385 | Treatment of Movement Disorders With Focused Ultrasound |
| Q38998571 | Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma |
Search more.